✦ LIBER ✦

159 Re-evaluation of plasma osteopontin as a tumor marker for mesothelioma

✍ Scribed by Shiomi, K.; Hagiwara, Y.; Segawa, T.; Maeda, M.; Miyamoto, H.; Takahasi, K.; Sakao, Y.; Sakuraba, M.; Hino, O.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Megakaryocyte potentiating factor as a t

✍ Iwahori, Kota; Osaki, Tadashi; Serada, Satoshi; Fujimoto, Minoru; Suzuki, Hideka 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 742 KB

Evaluation of γ-enolase as a tumor marke

✍ Koichi Fujita; Hajime Haimoto; Munehisa Imaizumi; Toshio Abe; Kanefusa Kato 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 741 KB

Evaluation of Serum Ferritin as a Tumor

✍ K.R. Friedrichs; C. Thomas; M. Plier; G.A. Andrews; P.S. Chavey; K.M. Young 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 149 KB

Clinical Evaluation of Neuropeptide Y as

✍ MASAHIKO SONE; TORAICHI MOURI; KAZUHIRO TAKAHASHI; KEIICHI ITOI; YUTAKA HAYASHI; 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB

Evaluation of plasma glutathione S-trans

✍ Yutaka Kobayashi; Teruo Amagasa; Eiji Fujii; Masashi Yamashiro 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 662 KB

Evaluation of plasma NSE (neuron specifi

✍ Ozeki, Y.; Kinuya, M.; Suga, T.; Takishima, K.; Mamiya, G.; Ogata, T.; Suzuki, T 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 133 KB